← TrialMatch
HomeTrials

Predictive Factors of Autonomy Loss in Real-life Cohort

The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the

Condition(s)Memory Disorders
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public health. The Investigators aim at developing a regional database, which includes the patient medical records on a prospective basis, in collaboration with the medical and administrative staff and with the University hospital computer science departments. The main objective is to study the predictive factors associated with change in functional autonomy level, measured every 6 to 12 months in centr
Who can participateInclusion Criteria: * Patients aged 18 years and older, undergoing a medical visit in a memory center or neuro-cognition service * Patients living at home or in housing * Patients with memory impairment, at all stage of the disease Exclusion Criteria: * Patients in institution * Patients under legal protection * Patients with a hearing or visual impairment, which prevents carrying out examinations
Ages18 Years
SexAll
Lead sponsorHospices Civils de Lyon
LocationsCaluire-et-Cuire, France; Lyon, France; Lyon, France; Saint-Etienne, France; Villeurbanne, France
Start date2020-09-09
NCT IDNCT03894254
Official listinghttps://clinicaltrials.gov/study/NCT03894254

🔍 Search all trials →